BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16904272)

  • 1. [Fanconi anemia: cellular and molecular features].
    Macé G; Briot D; Guervilly JH; Rosselli F
    Pathol Biol (Paris); 2007 Feb; 55(1):19-28. PubMed ID: 16904272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3R coordination by Fanconi anemia proteins.
    Macé G; Bogliolo M; Guervilly JH; Dugas du Villard JA; Rosselli F
    Biochimie; 2005 Jul; 87(7):647-58. PubMed ID: 15935541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular basis of Fanconi's anemia].
    Digweed M
    Klin Padiatr; 1999; 211(4):192-7. PubMed ID: 10472548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fanconi anaemia/BRCA pathway.
    D'Andrea AD; Grompe M
    Nat Rev Cancer; 2003 Jan; 3(1):23-34. PubMed ID: 12509764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks.
    Macé-Aimé G; Couvé S; Khassenov B; Rosselli F; Saparbaev MK
    Environ Mol Mutagen; 2010 Jul; 51(6):508-19. PubMed ID: 20120016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular biology of Fanconi anaemia--an old problem, a new insight.
    Ahmad SI; Hanaoka F; Kirk SH
    Bioessays; 2002 May; 24(5):439-48. PubMed ID: 12001267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fanconi anemia: genes and function(s) revisited].
    Papadopoulo D; Moustacchi E
    Med Sci (Paris); 2005; 21(8-9):730-6. PubMed ID: 16115458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fanconi anemia pathway--the way of DNA interstrand cross-link repair.
    Yao CJ; Du W; Zhang Q; Zhang F; Zeng F; Chen FP
    Pharmazie; 2013 Jan; 68(1):5-11. PubMed ID: 23444773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complex role of the FA proteins in providing genome stability].
    Kluzek K; Zdzienicka MZ
    Postepy Biochem; 2005; 51(4):387-94. PubMed ID: 16676573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Fanconi anemia proteins promote the four Rs: replication, recombination, repair, and recovery.
    Thompson LH; Hinz JM; Yamada NA; Jones NJ
    Environ Mol Mutagen; 2005; 45(2-3):128-42. PubMed ID: 15668941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer for the eventual treatment of Fanconi's anemia.
    Liu JM
    Semin Hematol; 1998 Apr; 35(2):168-79. PubMed ID: 9565158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deregulated apoptosis is a hallmark of the Fanconi anemia syndrome.
    Ridet A; Guillouf C; Duchaud E; Cundari E; Fiore M; Moustacchi E; Rosselli F
    Cancer Res; 1997 May; 57(9):1722-30. PubMed ID: 9135015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fanconi anemia is a highly penetrant cancer susceptibility syndrome.
    Dokal I
    Haematologica; 2008 Apr; 93(4):486-8. PubMed ID: 18379006
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxidative stress as a multiple effector in Fanconi anaemia clinical phenotype.
    Pagano G; Degan P; d'Ischia M; Kelly FJ; Nobili B; Pallardó FV; Youssoufian H; Zatterale A
    Eur J Haematol; 2005 Aug; 75(2):93-100. PubMed ID: 16000125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells.
    Kumaresan KR; Sridharan DM; McMahon LW; Lambert MW
    Biochemistry; 2007 Dec; 46(50):14359-68. PubMed ID: 18020456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fanconi anaemia and leukaemia - clinical and molecular aspects.
    Tischkowitz M; Dokal I
    Br J Haematol; 2004 Jul; 126(2):176-91. PubMed ID: 15238138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent.
    Centurion SA; Kuo HR; Lambert WC
    Exp Cell Res; 2000 Nov; 260(2):216-21. PubMed ID: 11035916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic subtyping of Fanconi anemia by comprehensive mutation screening.
    Ameziane N; Errami A; Léveillé F; Fontaine C; de Vries Y; van Spaendonk RM; de Winter JP; Pals G; Joenje H
    Hum Mutat; 2008 Jan; 29(1):159-66. PubMed ID: 17924555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.